AXL Series: MOUD for Youth and Older Adult Populations



Date & Location
Monday, June 26, 2023, 9:00 AM - Friday, June 26, 2026, 10:00 AM

Credits
AMA PRA Category 1 Credits™ (1.50 hours), ANCC Nursing Contact Hours (1.50 hours), CME-Designated Participation Credit (1.50 hours)

Overview

Review and discussion of:

  • Medication considerations for youth and older adult populations
  • Working with patient families
  • Service coordination related to common needs among young and older patients
  • Biomedical considerations related to older adult MOUD patients

Presenter
Marc Fishman, MD                                                                                                  
Medical Director: Maryland Treatment Centers/Mountain Manor
Psychiatry faculty: Johns Hopkins University School of Medicine

Learning Outcome
At the conclusion of this learning activity, (at least 75% of) participants will be able to employ at least two developmentally-informed treatment engagement strategies for youth or older adult patients with opioid use disorder. 

Disclosure
The following activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for this activity have reported the following financial relationship(s)* with ineligible company(ies)**. All of the relevant financial relationships listed for these individuals have been mitigated.

Marc Fishman, MD ~ is a consultant to Alkermes, Drug Delivery, LLC and Indivior and has a research grant from Alkermes.

Lisa Marsch, PhD ~ has stock ownership and royalties/patients for Pear Therapeutics and stock ownership in Square2 Systems.

Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this activity report NO financial relationship(s)* with any ineligible company(ies)**.

* A “financial relationship" includes employee, researcher (named as the PI), consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and/or an ownership interest (not including stocks owned in a managed portfolio).

** An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Bibliographic Material

  • Wenzel et al. Choice of extended release medication for OUD in young adults (buprenorphine or naltrexone): a pilot enhancement of the Youth Opioid Recovery Support (YORS) intervention. JSAT. 2021. In press.

  • Wenzel K and Fishman M. Mobile van delivery of extended-release buprenorphine and extended-release naltrexone for youth with OUD: An adaptation to the COVID-19 emergency. JSAT. In press. 2020

  • Hogue A, Becker S, Fishman M, Henderson C, Levy S. Youth OUD Treatment During and After COVID: Increasing Family Involvement across the Services Continuum. JSAT. In press. 2020.

  • Fishman M, Wenzel K, Scodes J, Pavlicova M, Lee J, Rotrosen J, Nunes E. Young adults have worse outcomes than older adults: Secondary analysis of a medication trial for opioid use disorder. J Adol Health. 2020.

  • Fishman M, Wenzel K, Vo H, Wildberger J, Burgower R. “A pilot randomized controlled trial of assertive treatment including family involvement and home delivery of medication for young adults with opioid use disorder.” Addiction. 2020.

  • Woody G, Fishman M. “Medication for Opioid-Addicted Youth – What are We Waiting For?” J Adol Health. 67: 9- 10. July 2020.

  • Monico L, Ludwig A, Lertch E, Dionne R, Fishman M, Schwartz R, Mitchell S. “Opioid overdose experiences in a sample of US adolescents and young adults: a thematic analysis." Addiction. 2020.

  • Vo H, Burgower R, Rozenberg I, Fishman M. Home-based Delivery of XR-NTX in Youth with Opioid Addiction. J Subst Abuse Treat. 85 (2018) 84–89. PMID: 28867062

  • Levy S, et al. A Novel Approach to Treating Adolescents with Opioid Use Disorder in Pediatric Primary Care. Substance Abuse. 2018

Accreditation

Dartmouth Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Dartmouth Health designates this Enduring Material for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Dartmouth Health Nursing Continuing Education Council is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity carries 1.50 contact hour(s).

Registration/Requirements for Successful Completion
You may claim credit for successful completion of this online course. In order to claim credit, you must follow these steps:

  1. Click the Register tab above. If you are not logged into your account, you will need to log in. Use the Forgot Your Password? button if you need to reset your password.
  2. Register for the activity.
  3. Click the Content/Tests tab and then View Content to view the recording. View the entire presentation.
  4. Complete the Post-Test (attestation).
  5. Click My Account in the menu bar; then click Evaluation.
  6. Complete and Submit the Evaluation.

Provider Contact Information
Provider contact information for questions regarding accreditation of the activity:

Center for Learning and Professional Development
CME/CNE Office
Dartmouth Health
[email protected]